Medical heating equipment is classified as a medical device in most jurisdictions, meaning it must comply with rigorous safety standards before it can be sold to hospitals. Understanding these requirements is non-negotiable for serious exporters.
Core International Standards: IEC 60601 Series
The IEC 60601 family of standards governs the safety and essential performance of medical electrical equipment. For radiant heating equipment, two standards are particularly relevant:
IEC 60601-2-35: Applies to heating equipment using blankets, pads, and mattresses for patient warming during surgical procedures and for prevention/treatment of hypothermia in clinical environments. Edition 2 was published in 2020 with Amendment 1 in 2023, with a transition period ending approximately December 2026 [5].
IEC 60601-2-57: Applies to non-laser light source equipment for medical use, covering wavelength ranges from 200nm to 3000nm—which includes infrared radiation used in radiant heaters. This standard addresses optical radiation risks, safety requirements, warning labels, and manufacturer information obligations. Edition 2 was published in 2023, with a transition period ending approximately July 2026 [5].
IEC 60601-1: The foundational standard for basic safety and essential performance of all medical electrical equipment. Edition 3.2 is now mandatory [5].
IEC 60601-1-2: Electromagnetic compatibility (EMC) requirements. Edition 4.1 applies [5].
What These Standards Mean for Your Product
Compliance isn't just about testing—it's about design, documentation, and ongoing quality management:
- Design Phase: Your product must be engineered to meet electrical safety, thermal safety, and optical radiation limits from the outset
- Risk Management: ISO 14971 risk management processes must be implemented and documented [5]
- Usability Engineering: IEC 62366 usability engineering requirements apply to ensure safe operation by clinical staff [5]
- Technical Documentation: Complete technical files including design specifications, test reports, risk assessments, and clinical evaluations
- Quality Management: ISO 13485 quality management system certification is typically required for market access
- Post-Market Surveillance: Ongoing monitoring of product performance and adverse events after market entry
2026 Compliance Deadlines: Multiple IEC 60601 standards have transition periods ending in 2026—IEC 60601-2-35 (December 2026) and IEC 60601-2-57 (July 2026). Exporters planning to enter medical markets should ensure products meet these standards before these deadlines
[5].
Southeast Asia Regulatory Landscape
Each Southeast Asian country has its own medical device regulatory framework, though ASEAN harmonization efforts are underway:
Malaysia: In January 2026, the Medical Device Authority (MDA) implemented Circular Letter No. 1/2026, classifying participation in tenders as 'placing in the market.' This means bidders must hold valid establishment licenses, implement GDPMD quality management systems, and assume post-market responsibilities [10].
Singapore: The most mature regulatory environment in the region, with HSA (Health Sciences Authority) oversight. Singapore accounts for 25%+ of regional med-tech output and serves as a regional innovation hub [9].
Thailand: New medical device labeling regulations came into effect in 2025, with mandatory compliance by June 20, 2026. Imported devices must be labeled within 120 days of import [9].
Indonesia: Over 1,300 hospitals and laboratories rely heavily on imported equipment. Regulatory framework continues to evolve under BPOM oversight [9].
ASEAN Medical Device Directive (AMDD): Ongoing harmonization efforts aim to create mutual recognition frameworks across member states. A Malaysia-Singapore MOU on regulatory reliance was announced in September 2025, with a pilot program running through February 2026 for Class B, C, and D devices [9].
Southeast Asia Medical Device Regulatory Summary
| Country | Regulatory Authority | Key Requirements | 2026 Updates |
|---|
| Malaysia | MDA | Establishment license, GDPMD, post-market surveillance | Circular Letter No. 1/2026: Tender participation = market placement [10] |
| Singapore | HSA | Product registration, QMS certification | Regional innovation hub, 500+ med-tech companies [9] |
| Thailand | Thai FDA | Product license, labeling compliance | June 20, 2026: Mandatory labeling within 120 days of import [9] |
| Indonesia | BPOM | Product registration, import license | 1,300+ hospitals, high import dependency [9] |
| ASEAN | AMDD Framework | Harmonization in progress | Malaysia-Singapore MOU pilot through Feb 2026 [9] |
Regulatory information from Southeast Asia med-tech market reports and compliance updates
[9],
[10]
